These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 16918403)

  • 1. Novel delivery technologies for protein and peptide therapeutics.
    Kumar TR; Soppimath K; Nachaegari SK
    Curr Pharm Biotechnol; 2006 Aug; 7(4):261-76. PubMed ID: 16918403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging protein delivery methods.
    Cleland JL; Daugherty A; Mrsny R
    Curr Opin Biotechnol; 2001 Apr; 12(2):212-9. PubMed ID: 11287240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in protein and peptide parenteral delivery approaches.
    Patel A; Cholkar K; Mitra AK
    Ther Deliv; 2014 Mar; 5(3):337-65. PubMed ID: 24592957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes.
    Thwala LN; Préat V; Csaba NS
    Expert Opin Drug Deliv; 2017 Jan; 14(1):23-36. PubMed ID: 27351299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel strategies in the oral delivery of antidiabetic peptide drugs - Insulin, GLP 1 and its analogs.
    Ismail R; Csóka I
    Eur J Pharm Biopharm; 2017 Jun; 115():257-267. PubMed ID: 28336368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Delivery of Therapeutic Proteins and Peptides: An Overview of Current Technologies and Recommendations for Bridging from Approved Intravenous or Subcutaneous Administration to Novel Oral Regimens.
    Philippart M; Schmidt J; Bittner B
    Drug Res (Stuttg); 2016 Mar; 66(3):113-20. PubMed ID: 26536331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier Mediated Systemic Delivery of Protein and Peptide Therapeutics.
    Zaman R; Othman I; Chowdhury EH
    Curr Pharm Des; 2016; 22(40):6167-6191. PubMed ID: 27510479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel non-invasive protein and peptide drug delivery approaches.
    Wallis L; Kleynhans E; Toit TD; Gouws C; Steyn D; Steenekamp J; Viljoen J; Hamman J
    Protein Pept Lett; 2014; 21(11):1087-101. PubMed ID: 25106909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration strategies for proteins and peptides.
    Ibraheem D; Elaissari A; Fessi H
    Int J Pharm; 2014 Dec; 477(1-2):578-89. PubMed ID: 25445533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein and peptide parenteral controlled delivery.
    Pawar R; Ben-Ari A; Domb AJ
    Expert Opin Biol Ther; 2004 Aug; 4(8):1203-12. PubMed ID: 15268656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation Approaches to Overcome Biopharmaceutical Limitations of Inhaled Peptides/Proteins.
    Onoue S; Suzuki H; Seto Y
    Curr Pharm Des; 2015; 21(27):3867-74. PubMed ID: 26290195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein drug oral delivery: the recent progress.
    Lee HJ
    Arch Pharm Res; 2002 Oct; 25(5):572-84. PubMed ID: 12433186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
    Andrade F; Videira M; Ferreira D; Sarmento B
    Nanomedicine (Lond); 2011 Jan; 6(1):123-41. PubMed ID: 21182424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles.
    Patel A; Patel M; Yang X; Mitra AK
    Protein Pept Lett; 2014; 21(11):1102-20. PubMed ID: 25106908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.
    Bak A; Leung D; Barrett SE; Forster S; Minnihan EC; Leithead AW; Cunningham J; Toussaint N; Crocker LS
    AAPS J; 2015 Jan; 17(1):144-55. PubMed ID: 25398427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal delivery of proteins and peptides.
    Swaminathan J; Ehrhardt C
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1489-503. PubMed ID: 23092138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives.
    Pawar VK; Meher JG; Singh Y; Chaurasia M; Surendar Reddy B; Chourasia MK
    J Control Release; 2014 Dec; 196():168-83. PubMed ID: 25305562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Approaches of Bioactive Peptide Molecules and Protein Drug Delivery Systems.
    Thotakura N; Kaushik L; Kumar V; Preet S; Babu PV
    Curr Pharm Des; 2018; 24(43):5147-5163. PubMed ID: 30727874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.